Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-drug interaction of SK-0403 and miglitol in Japanese male patients with type 2 diabetes
jRCT2080221125Phase 3
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of anagliptin in type 2 diabetes mellitus (T2DM), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoints: Effect of SK-0403 on miglitol pharmacokinetics, Effect of SK-0403 on miglitol pharmacodynamics and 1 more.
02
Drugs
anagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221125.